{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10586535", "DateCompleted": {"Year": "2000", "Month": "01", "Day": "20"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1180-4882", "JournalIssue": {"Volume": "24", "Issue": "5", "PubDate": {"Year": "1999", "Month": "Nov"}}, "Title": "Journal of psychiatry & neuroscience : JPN", "ISOAbbreviation": "J Psychiatry Neurosci"}, "ArticleTitle": "American ginseng extract reduces scopolamine-induced amnesia in a spatial learning task.", "Pagination": {"StartPage": "442", "EndPage": "452", "MedlinePgn": "442-52"}, "Abstract": {"AbstractText": ["To determine if HT-1001, an extract of American ginseng, affects scopolamine-induced memory and performance deficits in a spatial learning task, alters brain concentrations of aminergic neurotransmitters, and alters choline uptake in synaptosome preparations.", "Animal study.", "48 Sprague Dawley rats.", "Long-term oral administration of a test material or control solution. Intraperitoneal administration of scopolamine (2 mg/kg) 30 minutes before testing.", "Performance on Morris water maze task, choline uptake, aminergic neurotransmitter analysis, in vitro monoamine oxidase analysis (of compounds).", "HT-1001 protected against scopolamine-induced amnesia and increased choline uptake in synaptosomal preparations. HT-1001 did not alter brain concentrations of norepinephrine, dopamine, 5-HT (serotonin), 3,4-dihydroxyphenylacetic acid or 5-hydroxyindoleactic acid. HT-1001 had a very weak ability to inhibit monoamine oxidase activity in vitro.", "HT-1001 demonstrates a capacity to protect against scopolamine-induced memory deficits."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "CV Technologies, Edmonton, Alta. Duff@cvtechnologies.com"}], "Identifier": [], "LastName": "Sloley", "ForeName": "B D", "Initials": "BD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pang", "ForeName": "P K", "Initials": "PK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huang", "ForeName": "B H", "Initials": "BH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ba", "ForeName": "F", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "F L", "Initials": "FL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Benishin", "ForeName": "C G", "Initials": "CG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Greenshaw", "ForeName": "A J", "Initials": "AJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shan", "ForeName": "J J", "Initials": "JJ"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Canada", "MedlineTA": "J Psychiatry Neurosci", "NlmUniqueID": "9107859", "ISSNLinking": "1180-4882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Central Nervous System Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "DL48G20X8X", "NameOfSubstance": "Scopolamine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Central Nervous System Agents"}, {"QualifierName": [], "DescriptorName": "Ginsenosides"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Maze Learning"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mental Recall"}, {"QualifierName": ["drug effects"], "DescriptorName": "Orientation"}, {"QualifierName": [], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["toxicity"], "DescriptorName": "Scopolamine"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Jpn J Pharmacol. 1977 Jun;27(3):445-51", "ArticleIdList": ["199774"]}, {"Citation": "Brain Res Mol Brain Res. 1997 Jul;47(1-2):177-82", "ArticleIdList": ["9221915"]}, {"Citation": "Chem Pharm Bull (Tokyo). 1983 Jan;31(1):168-74", "ArticleIdList": ["6850933"]}, {"Citation": "Chem Pharm Bull (Tokyo). 1983 Mar;31(3):1059-66", "ArticleIdList": ["6883602"]}, {"Citation": "Chem Pharm Bull (Tokyo). 1983 Oct;31(10):3691-7", "ArticleIdList": ["6671229"]}, {"Citation": "Biomed Biochim Acta. 1987;46(8-9):S646-9", "ArticleIdList": ["3435520"]}, {"Citation": "J Ethnopharmacol. 1988 Feb-Mar;22(2):173-81", "ArticleIdList": ["3374151"]}, {"Citation": "Planta Med. 1989 Oct;55(5):429-33", "ArticleIdList": ["2813579"]}, {"Citation": "Chin Med J (Engl). 1990 Nov;103(11):932-8", "ArticleIdList": ["2177392"]}, {"Citation": "Pharmacology. 1991;42(4):223-9", "ArticleIdList": ["1852782"]}, {"Citation": "J Chromatogr. 1991 Jun 14;567(1):49-56", "ArticleIdList": ["1680873"]}, {"Citation": "Neurochem Int. 1992 Jul;21(1):1-5", "ArticleIdList": ["1338897"]}, {"Citation": "Psychopharmacology (Berl). 1994 May;114(4):651-6", "ArticleIdList": ["7855228"]}, {"Citation": "Gen Pharmacol. 1994 Oct;25(6):1071-7", "ArticleIdList": ["7875528"]}, {"Citation": "Zhongguo Yao Li Xue Bao. 1994 Sep;15(5):392-8", "ArticleIdList": ["7717059"]}, {"Citation": "Acta Neuropathol. 1996;91(1):15-22", "ArticleIdList": ["8773141"]}, {"Citation": "Biochem Pharmacol. 1982 Apr 1;31(7):1417-24", "ArticleIdList": ["7092930"]}]}], "History": [{"Year": "1999", "Month": "12", "Day": "10"}, {"Year": "1999", "Month": "12", "Day": "10", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "12", "Day": "10", "Hour": "0", "Minute": "0"}, {"Year": "1999", "Month": "11", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10586535", "PMC1189058"]}}], "PubmedBookArticle": []}